Literature DB >> 7534920

Formation and characterization of cisplatin-loaded poly(benzyl l-glutamate) microspheres for chemoembolization.

C Li1, D J Yang, S Nikiforow, W Tansey, L R Kuang, K C Wright, S Wallace.   

Abstract

Chemoembolization using microspheres of 100- to 200-microns is a useful way to treat primary and secondary hepatic tumors. In a search for a better embolic material, we described in detail the preparation and characterization of a poly(benzyl l-glutamate) (PBLG) microspheres containing cisplatin (CDDP). We determined the optimal experimental conditions to produce spherical free-flowing microspheres that were able to release drug content (44% [w/w] CDDP) in a sustained manner. We found that solvent viscosity played a key role in determining the resulting microsphere characteristics. Microscopic studies showed that increasing the polymer concentration (to 10% [w/v]) and the viscosity of the organic phase produced microspheres with uniform drug distribution. Increasing polymer concentration also markedly improved drug incorporation efficiency. In vitro release studies revealed that the release of CDDP was a function of drug loading; microspheres with a higher amount of entrapped CDDP had a slower release rate. This observation and the fact that CDDP/PBLG microspheres did not show "burst effect" at higher loading is ascribed to the formation of uniformly distributed drug crystal networks within the polymer matrix. The favorable properties of the CDDP/PBLG system warrants its further evaluation on experimental animal models for the treatment of hepatic tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7534920     DOI: 10.1023/a:1018979703726

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.

Authors:  Nicholas A Peppas
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

2.  A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge.

Authors:  Y Sasaki; S Imaoka; H Kasugai; M Fujita; S Kawamoto; S Ishiguro; J Kojima; O Ishikawa; H Ohigashi; H Furukawa
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

3.  The potential for poly-alpha-amino acids as biomaterials.

Authors:  J M Anderson; D F Gibbons; R L Martin; A Hiltner; R Woods
Journal:  J Biomed Mater Res       Date:  1974

4.  Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs.

Authors:  T Kato; R Nemoto; H Mori; M Takahashi; M Harada
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

Review 5.  Fundamental studies with cisplatin.

Authors:  B Rosenberg
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

6.  Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride.

Authors:  T Ichihara; K Sakamoto; K Mori; M Akagi
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

7.  5-Fluorouracil:carnauba wax microspheres for chemoembolization: an in vitro evaluation.

Authors:  S Benita; O Zouai; J P Benoit
Journal:  J Pharm Sci       Date:  1986-09       Impact factor: 3.534

Review 8.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

9.  Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization.

Authors:  G Spenlehauer; M Veillard; J P Benoît
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

10.  Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.

Authors:  D J Kerr; N Willmott; J H McKillop; J Cummings; H J Lewi; C S McArdle
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

View more
  1 in total

1.  Cisplatin-incorporated nanoparticles of poly(acrylic acid-co-methyl methacrylate) copolymer.

Authors:  Kyung Dong Lee; Young-Il Jeong; Da Hye Kim; Gyun-Taek Lim; Ki-Choon Choi
Journal:  Int J Nanomedicine       Date:  2013-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.